Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

670

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Constipation
Interventions
DRUG

Tegaserod

Trial Locations (59)

10016

Investigative Site, New York

10022

Investigative Site, New York

11758

Investigative Site, North Massapequa

19056

Investigative Site, Levittown

22903

Investigative Site, Charlottesville

27103

Investigative Site, Winston-Salem

27401

Investigative Site, Greensboro

28112

Investigative Site, Monroe

28210

Investigative Site, Charlotte

32168

Investigative Site, New Smyrna Beach

32207

Investigative Site, Jacksonville

32720

Investigative Site, DeLand

33176

Investigative Site, Miami

33607

Investigative Site, Tampa

33773

Investigative Site, Largo

34609

Investigative Site, Springhill

36608

Investigative Site, Mobile

37404

Investigative Site, Chattanooga

45440

Investigative Site, Dayton

46123

Investigative Site, Avon

46254

Investigative Site, Indianapolis

47714

Investigative Site, Evansville

60640

Investigative Site, Chicago

62220

Investigative Site, Belleville

66206

Investigative Site, Prairie Village

66212

Investigative Site, Overland Park

68114

Investigative Site, Omaha

68134

Investigative Site, Omaha

71103

Investigative Site, Shreveport

72117

Investigative Site, North Little Rock

73112

Investigative Site, Oklahoma City

75110

Investigative Site, Corsicana

76034

Investigative Site, Colleyville

77005

Investigative Site, Houston

77701

Investigative Site, Beaumont

78229

Investigative Site, San Antonio

80234

Investigative Site, Northglenn

84132

Investigative Site, Salt Lake City

85029

Investigative Site, Phoenix

85050

Investigative Site, Phoenix

85712

Investigative Site, Tucson

89048

Investigative Site, Pahrump

90073

Investigative Site, Los Angeles

90240

Investigative Site, Downey

90505

Investigative Site, Torrance

90620

Investigative Site, Buena Park

92024

Investigative Site, Encinitas

92037

Investigative Site, La Jolla

92103

Investigative Site, San Diego

92691

Investigative Site, Mission Viejo

92708

Investigative Site, Fountain Valley

94115

Investigative Site, San Francisco

97232

Investigative Site, Portland

98104

Investigative Site, Seattle

06010

Investigative Site, Bristol

02118

Investigative Site, Boston

02215

Investigative Site, Boston

07936-1080

Novartis Pharmaceutical Corporation, East Hanover

17033-085

Investigative Site, Hershey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY